RFK Jr. and the Perils of Peptides Washington Monthly In a major policy shift, the U.S. Food and Drug Administration is reconsidering restrictions on several controversial peptides, including trending compounds like BPC 157 and Melanotan II. The move comes as demand for The Peptide Craze Part 2: BPC 157, NAD and the Truth Behind the Longevity Molecule Hype FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling Are Peptides Safe? What Older Adults Need to Know BPC 157: The peptide with big claims and scant evidence STAT